Search Within

Jedd D Wolchok

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (61)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (139)
  2. Epidemiology and Biostatistics (139)
  3. GSK Faculty (139)
  4. Melanoma and Immunotherapeutics Service (139)
  5. Solid Tumor Oncology Division (139)
  6. Biostatistics Service (127)

More Groups

People
  1. Katherine Panageas (92)
  2. Paul Chapman (61)
  3. Michael Postow (48)
  4. Margaret Callahan (40)
  5. Jianda Yuan (38)
  6. Taha Merghoub (34)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (10)
  4. 2021 (7)
  5. 2020 (10)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (43)
  2. Journal for ImmunoTherapy of Cancer (12)
  3. Cancer Research (10)
  4. Clinical Cancer Research (9)
  5. Nature (5)
  6. Cancer Immunology Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. American Association for Cancer Research (24)
  3. Biomed Central Ltd (12)
  4. Nature Publishing Group (9)
  5. Cell Press (5)
  6. Lippincott Williams & Wilkins (5)

More Publishers

Results (139)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety of infusing ipilimumab (ipi) over 30 minutes (min)
    Meeting Abstract

    Momtaz, P.; Park, V.; Panageas, K.; Guillen, J. D.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilinournab (ipi)
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J. D.; Dong, Z. W.; Emerson, R.; Robins, H.; Redmond, D.; Zhao, C. J.; Mu, Z. Y.; Wong, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Mcarthur, H. L.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma
    Meeting Abstract

    Ariyan, C. E.; Lefkowitz, R. A.; Panageas, K.; Callahan, M. K.; Misholy, O.; Bello, D.; Fisher, C.; Kotin, A.; Siegelbaum, R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC)
    Meeting Abstract

    Page, D. B.; Yuan, J. D.; Ginsberg, A.; Dong, Z.; Wong, P.; Emerson, R.; Sung, J. S.; Comstock, C.; Solomon, S. B.; Sacchini, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save